𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Crohn's disease activity assessed by fecal calprotectin and lactoferrin: Correlation with Crohn's disease activity index and endoscopic findings

✍ Scribed by Taina Sipponen; Erkki Savilahti; Kaija-Leena Kolho; Hannu Nuutinen; Ulla Turunen; Martti Färkkilä


Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
137 KB
Volume
14
Category
Article
ISSN
1078-0998

No coin nor oath required. For personal study only.

✦ Synopsis


Background: Correlation of endoscopic Crohn's disease activity with fecal calprotectin and lactoferrin is insufficiently studied. We evaluated the clinical significance of these neutrofil-derived proteins in assessment of Crohn's disease activity by comparing them with endoscopic disease activity and with Crohn's disease activity index (CDAI) and serum CRP.

Methods: A total of 77 CD patients underwent one or more ileocolonoscopies (n ϭ 106) with scoring of Crohn's disease index of severity (CDEIS). Patients provided stool samples for calprotectin and lactoferrin measurements and blood samples for CRP. Clinical activity was based on the CDAI.

Results:

Both fecal calprotectin and lactoferrin correlated significantly with CDEIS (Spearman's r 0.729 and 0.773, P Ͻ 0.001). With a cutoff level of 200 g/g for a raised fecal calprotectin concentration, sensitivity was 70%, specificity 92%, positive predictive value (PPV) 94%, and negative predictive value (NPV) 61% in predicting endoscopically active disease (CDEIS Ն 3). A fecal lactoferrin concentration of 10 g/g as the cutoff value gave a sensitivity, specificity, PPV, and NPV of 66%, 92%, 94%, and 59%. Sensitivity of CDAI Ն 150 to detect endoscopically active disease was only 27%, specificity 94%, PPV 91%, and NPV 40%. A raised serum CRP (Ͼ 5 mg/l) gave a sensitivity, specificity, PPV, and NPV of 48%, 91%, 91%, and 48%.

Conclusions:

For evaluation of Crohn's disease activity, based on endoscopic findings, more sensitive surrogate markers than is CDAI or CRP are fecal calprotectin and lactoferrin. These prove to be useful tools for estimation of disease activity in Crohn's disease.


📜 SIMILAR VOLUMES


Fecal calprotectin, lactoferrin, and end
✍ Taina Sipponen; Erkki Savilahti; Päivi Kärkkäinen; Kaija-Leena Kolho; Hannu Nuut 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB 👁 1 views

Background: Fecal calprotectin and lactoferrin are promising noninvasive biomarkers for intestinal inflammation. In Crohn's disease (CD), during anti-TNF-alpha (TNF-␣) treatment, the clinical significance of these markers has, however, been insufficiently explored. Methods: Among CD patients receiv

Assessment of endoscopic activity index
✍ Marie-Armelle Denis; Catherine Reenaers; Fernand Fontaine; Jacques Belaïche; Edo 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 111 KB 👁 1 views

Background: Patients with clinically active Crohn's disease (CD), defined by a Crohn's Disease Activity Index (CDAI) Ͼ150, may have normal C-reactive protein (CRP) serum levels. In such cases, it is difficult to know whether these patients have really active disease or rather functional symptoms. Th

Ulcerative colitis: Correlation of the R
✍ Alain M. Schoepfer; Christoph Beglinger; Alex Straumann; Michael Trummler; Pietr 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 144 KB 👁 1 views

## Background: The accuracy of noninvasive markers for the detection of endoscopically active ulcerative colitis (UC) according the Rachmilewitz Score is so far unknown. The aim was to evaluate the correlation between endoscopic disease activity and fecal calprotectin, Clinical Activity Index, C-r

Linking genetic susceptibility to Crohn'
✍ Silke Schmechel; Astrid Konrad; Julia Diegelmann; Jürgen Glas; Martin Wetzke; Ek 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 222 KB 👁 1 views

## Background: We analyzed the influence of Crohn's disease (CD)associated IL23R gene variants on IL-22 that is expressed in IL-23Rϩ Th17 cells. Methods: IL-22 serum levels were measured in 242 CD patients and in 31 healthy controls. Subanalyses included serum levels of IL-6, TNF-␣, IL-17A, IL-17